Category: topical
Topical 0.25% formulation for androgenetic alopecia — same 5α-reductase type II inhibition as oral finasteride but with much lower systemic exposure (<5%) → reduced sexual / cognitive side-effect signal. Compounded or specialty-pharmacy product.
TD: 6h